BA-3241

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameBA-3241
Drug Alias NameBA-3241BA3241BA 3241
ClassificationBiologics > T cell engagersBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Trop-2CD3 T-cell engagersAnti-CD3
TargetsTumor-associated calcium signal transducer 2T cell surface glycoprotein CD3
Therapy Area/IndicationsCarcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBioAtla Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioAtla Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Squamous Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A